{
    "organizations": [],
    "uuid": "995e39baead1dd2e9f5d5c351194eaaf3232f30e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-arbutus-consolidates-hbv-business/brief-arbutus-consolidates-hbv-business-around-warminster-pa-site-idUSFWN1PY12E",
    "ord_in_thread": 0,
    "title": "BRIEF-Arbutus Consolidates HBV Business Around Warminster, PA Site",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Arbutus Biopharma Corp:\n* ARBUTUS BIOPHARMA CORP - SITE CONSOLIDATION AND ORGANIZATIONAL RESTRUCTURING TO BETTER ALIGN ITS HBV BUSINESS IN WARMINSTER, PA\n* ARBUTUS BIOPHARMA CORP - TO ACHIEVE ALIGNMENT, CO WILL REDUCE ITS GLOBAL WORKFORCE BY ABOUT 31 PERCENT AND PLANS TO CLOSE ITS BURNABY FACILITY\n* ARBUTUS BIOPHARMA CORP - WILL INCUR RESTRUCTURING COSTS RELATED TO WORKFORCE REDUCTION AND SITE CLOSURE OF ABOUT $5.0 MILLION\n* ARBUTUS BIOPHARMA CORP - ‍RESTRUCTURING COSTS WILL BE PRIMARILY PAID IN CASH IN Q2 OF 2018​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T21:52:00.000+02:00",
    "crawled": "2018-02-09T17:07:36.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "arbutus",
        "biopharma",
        "corp",
        "arbutus",
        "biopharma",
        "corp",
        "site",
        "consolidation",
        "organizational",
        "restructuring",
        "better",
        "align",
        "hbv",
        "business",
        "warminster",
        "pa",
        "arbutus",
        "biopharma",
        "corp",
        "achieve",
        "alignment",
        "co",
        "reduce",
        "global",
        "workforce",
        "percent",
        "plan",
        "close",
        "burnaby",
        "facility",
        "arbutus",
        "biopharma",
        "corp",
        "incur",
        "restructuring",
        "cost",
        "related",
        "workforce",
        "reduction",
        "site",
        "closure",
        "million",
        "arbutus",
        "biopharma",
        "corp",
        "cost",
        "primarily",
        "paid",
        "cash",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}